PeptidePedia The community reference

HOMA-IR (revision 4)

Old revision·06:54, 23 Oct 2024·Chromatokid

This is an old revision of this page, as it stood at 06:54, 23 Oct 2024, saved by Chromatokid with the summary expand §Behaviour under weight loss and incretin therapy. It may differ substantially from the current revision, and any error it contains may since have been corrected.
HOMA-IR
Full nameHomeostatic model assessment of insulin resistance
InputsFasting glucose and fasting insulin
Reference methodHyperinsulinaemic-euglycaemic clamp
Topic infobox · conventions

HOMA-IR is an index of insulin resistance derived from a single fasting sample. In its original linear approximation it is the product of fasting glucose and fasting insulin divided by a constant, and it correlates moderately with clamp-derived measures of insulin sensitivity across populations.[1]

Its appeal is that it requires one blood draw rather than a several-hour clamp. Its weakness is that it is a model-derived approximation from two values, inherits the poor standardisation of insulin assays, and describes hepatic rather than peripheral insulin resistance most directly.[2]

Calculation and the two forms

[edit]

The original linear approximation is

\text{HOMA-IR} = (\text{glucose}\text{mmol/L} \times \text{insulin}\text{mU/L}) / 22.5

A revised non-linear computer model, HOMA2, was published later and gives different values, particularly at the extremes. The two are not interchangeable, and a figure quoted without saying which was used is ambiguous.[2]

References

  1. ^ Matthews DR, Hosker JP, Rudenski AS, et al. "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man." Diabetologia 28(7):412–419 (1985). PMID 3899825.
  2. ^ a b Wallace TM, Levy JC, Matthews DR. "Use and abuse of HOMA modeling." Diabetes Care 27(6):1487–1495 (2004). PMID 15161807.